Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 5 | Cell & Bioscience

Fig. 5

From: miR-26a inhibits atherosclerosis progression by targeting TRPC3

Fig. 5

TRPC3 was a target of miR-26a in HAECs. a Schematic of the interaction sites of wild-type or mutated TRPC3-3′UTR with miR-26a. b Luciferase activity was measured by luciferase reporter assay in HAECs after cotransfection with WT-TRPC3 or MUT-TRPC3 and miR-26a or miR-NC. c The protein level of TRPC3 in HAECs treated with miR-26a, anti-miR-26a, or corresponding controls were determined by western blot. *P < 0.05

Back to article page